Cariprazine and Dronedarone: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 16, 2026 · Source data updated Jul 16, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Dronedarone
Cariprazine
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Dronedarone (Multaq) can slow down the way your body breaks down cariprazine (Vraylar). When that happens, more cariprazine and its active breakdown product build up in your body. That can mean stronger effects and more side effects, like feeling restless, sleepy, dizzy, or having muscle stiffness or shakiness.
The good news is that this is very manageable. Your care team knows about this combination and can simply use a lower cariprazine dose and keep a closer eye on how you feel. Please don't stop or change either medicine on your own. Just check in with your doctor or pharmacist so they can tailor your dose safely.
Mechanism: Dronedarone is a moderate CYP3A4 inhibitor; cariprazine is a CYP3A4 substrate. Inhibition reduces metabolism, increasing exposure (AUC/Cmax) of cariprazine and its active metabolite didesmethylcariprazine (DDCAR). Neither drug is a prodrug here, so effect is increased antipsychotic exposure and side-effect risk.
Evidence: Probable; severity major; onset unspecified.
Management (per labeling for a moderate 3A4 inhibitor):
- New start (schizophrenia/bipolar mania): 1.5 mg PO every other day.
- Bipolar depression/adjunctive MDD: 1.5 mg every other day.
- Stable on 1.5-3 mg daily: reduce to 1.5 mg every other day.
- Stable on 4.5-6 mg daily: reduce to 1.5 mg once daily.
- On dronedarone discontinuation, cariprazine dose may need re-titration.
Monitor for EPS, akathisia, sedation.
What happens
Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure
Interaction Deep Dive
Taking cariprazine (which is metabolized by CYP3A4) together with a moderate CYP3A4 inhibitor can raise the levels of both cariprazine and didesmethylcariprazine, its active metabolite. For patients starting cariprazine while already receiving a moderate CYP3A4 inhibitor (in schizophrenia or bipolar mania), the initial dose should be 1.5 mg orally every other day, with an increase to 1.5 mg orally every other day if warranted, guided by tolerability and clinical response. In the setting of bipolar depression or as adjunctive therapy for MDD, a patient on a moderate CYP3A4 inhibitor should take 1.5 mg orally every other day. If a moderate CYP3A4 inhibitor is being added to an established cariprazine regimen, the following adjustments apply: for those already receiving 1.5 or 3 mg once daily, reduce cariprazine to 1.5 mg orally every other day when starting the inhibitor; for those on 4.5 or 6 mg once daily, change cariprazine to 1.5 mg orally once daily upon starting the inhibitor. Once the moderate CYP3A4 inhibitor is stopped, the cariprazine dose may require an increase according to clinical response and tolerability1.
Why it happens (mechanism)
Inhibition of CYP3A4-mediated metabolism of cariprazine
How to manage this interaction
This combination is manageable. Your care team will typically lower your cariprazine dose and watch you more closely while you take both medicines together.
- Keep taking both exactly as prescribed unless your doctor tells you otherwise.
- Depending on your current cariprazine dose, your team may switch you to a lower dose or to every-other-day dosing.
- If dronedarone is later stopped, your cariprazine dose may need to be raised again based on how you respond.
- Tell your prescriber or pharmacist if you notice new restlessness, muscle stiffness, tremor, or drowsiness.
The exact dose will be individualized by your care team.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) In drug interaction studies, giving cariprazine 1.5 mg/day together with erythromycin (a moderate CYP3A4 inhibitor) 500 mg twice daily for 21 days led to an increase in cariprazine AUC (0 to 24 hours) and Cmax of roughly 50% 1. In one study that enrolled only White males receiving cariprazine 1.5 mg/day and erythromycin 500 mg twice daily (n=40), AUCs rose by 38% (cariprazine), 11% (desmethylcariprazine, an active metabolite), and 60% (didesmethylcariprazine, an active metabolite), and Cmax rose by 34%, 16%, and 62%, respectively. Tmax was not altered by coadministration with erythromycin 2.
Common questions
Can I take Cariprazine and Dronedarone together?
Dronedarone raises cariprazine levels by slowing its breakdown, so your doctor will likely use a lower cariprazine dose and monitor you more closely. Keep taking both as prescribed and report any new side effects. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Cariprazine and Dronedarone interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Cariprazine and Dronedarone interaction managed?
This combination is manageable. Your care team will typically lower your cariprazine dose and watch you more closely while you take both medicines together. Keep taking both exactly as prescribed unless your doctor tells you otherwise. Depending on your current cariprazine dose, your team may switch you to a lower dose or to every-other-day dosing. If dronedarone is later stopped, your cariprazine… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Questions for your pharmacist
- Does my dose of Cariprazine or Dronedarone need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (2)
- Product Information: VRAYLAR(R) oral capsules, cariprazine oral capsules. AbbVie Inc. (per FDA), North Chicago, IL, 2024. DailyMed
- Szabo M, Hujber Z, Harsanyi J, et al: Coadministration of cariprazine with a moderate CYP3A4 inhibitor in patients with schizophrenia: implications for dose adjustment and safety monitoring. Clin Pharmacokinet 2024; 63(10):1501-1510. PubMed
Keep reading about Dronedarone
Keep reading about Cariprazine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist